My NCBI | Sign In
RSS Settings
  • Search: Casellini CM[au]

Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 5

    1.

    [Exenatide trials for the treatment of type 2 diabetes]

    Fernández Landó L, Casellini CM.

    Medicina (B Aires). 2009;69(4):447-57. Spanish. PMID: 19770100 [PubMed - in process]Related articles

    2.

    Clinical manifestations and current treatment options for diabetic neuropathies.

    Casellini CM, Vinik AI.

    Endocr Pract. 2007 Sep;13(5):550-66. Review.PMID: 17872358 [PubMed - indexed for MEDLINE]Related articles

    3.

    A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.

    Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ 3rd, Wolka AM, Vinik AI.

    Diabetes Care. 2007 Apr;30(4):896-902.PMID: 17392551 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Diabetic neuropathies: clinical manifestations and current treatment options.

    Vinik A, Ullal J, Parson HK, Casellini CM.

    Nat Clin Pract Endocrinol Metab. 2006 May;2(5):269-81. Review.PMID: 16932298 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pioglitazone treatment improves nitrosative stress in type 2 diabetes.

    Vinik AI, Ullal J, Parson HK, Barlow PM, Casellini CM.

    Diabetes Care. 2006 Apr;29(4):869-76.PMID: 16567830 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity